Company Filing History:
1 out of 12 
1 out of 93 
1 out of 5 
Years Active: 2013-2015
Title: **Inventor Spotlight: Carmen Burtea**
Introduction
Carmen Burtea, an innovative scientist based in Mons, Belgium, has made significant contributions to the field of biotechnology. With two patents to her name, her work focuses primarily on the development of diagnostic compounds and synthetic peptides that target specific biological markers associated with various diseases.
Latest Patents
Carmen's latest patents showcase her expertise and innovation in the health sector. The first patent involves "Molecules specifically binding pancreatic beta cells biomarkers," which provides a synthetic peptide molecule consisting of 25 amino acids that specifically binds to the FXYD2-gamma isoform of pancreatic beta cells. This invention holds the potential for advancing diabetes research and treatment.
Her second patent, "Compounds for the diagnosis of diseases associated with VCAM expression," relates to a compound characterized by the general formula: Signal-Linker-Peptide. This formula incorporates a VCAM-targeting peptide that is designed to enhance the diagnosis of diseases where VCAM plays a critical role. The specificity of the peptide CMKTDTRLC shows promise in developing new therapeutic strategies.
Career Highlights
Carmen has worked at esteemed institutions including Université de Mons and Université Libre de Bruxelles, where her research has centered around peptide innovation and biomarker identification. Her dedication to advancing scientific knowledge through research has positioned her as a notable figure in her field.
Collaborations
Throughout her career, Carmen has collaborated with various professionals, including notable coworkers like Robert Muller and Decio L Eizirik. These collaborations have enriched her research experience and facilitated advancements in her projects.
Conclusion
Carmen Burtea is a remarkable inventor whose work promises to make significant impacts in the health and biotechnology sectors. Her patents highlight her commitment to innovation and the ongoing effort to improve medical diagnostics and therapies. As she continues her research, the scientific community eagerly anticipates her future contributions.